Industry Trends

Sunny Kumar, MD, partner at GSR Ventures speaks about venture capital in clinical research at the SCOPE 2023 conference in Orlando, FL.

Joan Chambers, senior director of marketing, communication & education at CISCRP notes her key takeaways from the SCOPE 2023 conference in Orlando, FL.

Joan Chambers, senior director of marketing, communication & education for CISCRP names the three biggest challenges facing clinical trials at the SCOPE 2023 conference in Orlando, FL.

Murray L. Aitken, SVP of IQVIA offers insights that small biopharma organizations can take away from larger companies at the SCOPE 2023 conference in Orlando, FL.

Hope Meely, chief clinical officer at Slope, offers a look into what she believes is the most important clinical trial development over the past five years.

Hope Meely, chief clinical officer at Slope, dives into what she envisions the clinical trial sector to develop in 2023.

Sunny Kumar, MD, partner at GSR Ventures speaks about how healthcare and clinical trials can work together to create a greater impact at the SCOPE 2023 conference in Orlando, FL.

Len Rosenberg, head of clinical operations at Beat AML, reveals how changing the backbone treatment to a different regimen is beneficial to the patient, in terms of the safety with the same efficacy.

Len Rosenberg, head of clinical operations at Beat AML, comments on how factors, such as proper data collection and reporting techniques, can prove to be efficient and help save lives.

Sunny Kumar, MD, partner at GSR Ventures speaks about areas of investment in clinical trials at the SCOPE 2023 conference in Orlando, FL.

Murray L. Aitken, SVP of IQVIA speaks about the requirements of small biopharma clinical development at the SCOPE 2023 conference in Orlando, FL.

Murray L. Aitken, SVP of IQVIA speaks about how biopharma companies can take advantage of present opportunities at the SCOPE 2023 conference in Orlando, FL.

SCOPE session discusses key challenges of evaluating potential providers.

Panel at SCOPE discusses applying novel evidence in regulatory decision-making.

Panel at SCOPE discusses the possibilities of research in a post-COVID world.

Seagen, an oncology biotech, emphasizes personalization as part of its DE&I strategy.

DCTs and RWD among topics for industry to focus on moving into 2023.

Strong shift to DCTs, regulatory changes, and increased focus on diversity among main industry talking points in 2022.

Industry must act now to minimize effects of COVID-19 on clinical research.

With large shift to decentralized strategies, industry roles appear set for change.

Pandemic sparks new long-term plan for success in R&D.

Data, patient recruitment, and regulators all highlighted in these three predictions for the new year.

Insights from Syneos Health’s 2022 Health Trends: Insights for Industry Change Agent.

Top predictions for the major trends that will shape clinical trial design in 2022.

What the industry’s most inspiring technology innovators see coming in 2022.

The full potential of artificial intelligence is still yet to be realized.

Findings from Florence Healthcare’s State of Clinical Trial Technology Industry survey about how clinical operations technology changed in 2020 and how they expected it to evolve throughout this year.

Lessons from six months of conducting clinical trials during the COVID-19 pandemic

The perfect storm of industry growth, opportunity, and demand is translating to solid salary and satisfaction levels among clinical trial professionals, according to new survey.